ZAFGEN, INC. ZFGN Cash Flow

Zafgen, inc. (ZFGN)
CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash flows from operating activities:
Net loss
-35,892	-45,406	-52,725	-54,878	-58,524	-61,368	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities
Net loss
-	-	-	-	-	-	-	-	-	-	-	0	-53,153	-	-70,613	-75,822	-78,550	-74,286	-62,043	-56,848	-45,492	-36,478	0	0	0
Stock-based compensation expense
4,131	5,497	6,845	8,441	9,237	9,627	9,439	9,335	8,766	8,301	8,206	8,606	9,358	10,113	0	0	0	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	13	23	29	37	43	0	0	0	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Depreciation expense
288	263	237	267	262	261	259	201	197	188	199	199	203	212	194	158	115	70	33	24	18	16	0	0	0
Loss on disposal of fixed assets
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized foreign currency transaction losses (gains)
-48	-5	-44	-7	-48	-76	-30	-49	11	46	-136	-93	-51	-6	224	64	8	-82	-207	-195	-159	-93	0	0	0
Premium on marketable securities, net
-	-	-	-	-	6	65	138	152	359	338	331	426	340	1,193	1,594	1,819	2,036	0	0	0	-	-	-	-
Amortization of discount on marketable debt securities
557	788	1,031	1,120	942	670	318	-5	-171	-246	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of premium on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,421	1,581	1,521	1,243	0	0	0	-	-	-	-
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
-678	-729	-1,190	-478	-161	-199	385	-316	42	569	492	208	44	-413	-439	191	-463	363	670	-224	1,466	1,121	0	0	0
Tax incentive receivable
-	-1,288	-966	-80	179	666	0	0	0	-	-	-	-	-970	201	577	929	1,014	298	13	-398	-1,133	0	0	0
Accounts payable
-2,823	-2,958	273	-1,009	-789	432	-53	-1,577	1,886	448	-964	1,960	-1,236	-4,625	-484	-1,810	-258	4,914	3,072	2,732	2,447	815	0	0	0
Accrued restructuring costs
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses and other
-	-	-	-	-	628	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses
0	-	-	-	0	-	-	-	-	-	-1,453	-2,213	-2,817	-2,254	-1,818	711	2,897	3,192	-3,152	2,978	2,967	2,327	0	0	0
Net cash used in operating activities
-32,928	-40,783	-42,811	-48,157	-50,693	-51,487	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-45,893	-	-61,253	-66,359	-66,228	-59,554	-53,324	-43,466	-35,308	-28,241	0	0	0
Cash flows from investing activities:
Proceeds from sales and maturities of marketable debt securities
95,728	109,471	127,370	124,264	113,824	110,388	122,987	132,412	139,559	150,213	159,398	179,934	180,958	188,600	0	0	0	-	-	-	-	-	-	-	-
Proceeds from maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Purchases of marketable debt securities
51,734	82,861	82,206	142,419	137,733	117,147	131,308	93,082	94,599	114,511	119,535	123,921	134,858	136,528	146,892	198,766	223,001	287,491	0	0	0	-	-	-	-
Purchases of property and equipment
-	764	491	497	109	108	123	59	46	55	28	16	270	660	1,031	1,105	968	595	240	197	80	58	0	0	0
Net cash provided by investing activities
42,649	25,263	44,090	-18,951	-24,018	-6,867	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	45,865	-	49,994	5,040	-8,116	-92,118	-164,794	-136,312	-127,039	-57,315	0	0	0
Cash flows from financing activities:
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	442	0	0	0
Proceeds from issuance of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,386	0	0	0
Repayment of notes payable
0	-	-	-	-	-	-	-	-	3,633	3,119	3,056	2,995	2,935	0	0	0	-	-	-	-	-	-	-	-
Proceeds from exercise of common stock options and employee stock purchase plan
109	194	1,904	2,108	2,194	2,360	591	427	416	195	195	280	205	220	233	591	953	974	0	0	0	-	-	-	-
Proceeds from public offerings, net of commissions and underwriting discounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	130,044	0	0	0	-	-	-	-
Payments of public offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	473	473	1,367	1,958	2,312	0	0	0
Net cash (used in) provided by financing activities
-7,164	-5,261	-1,744	64,942	66,742	66,908	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash, cash equivalents and restricted cash
2,557	-20,781	-465	-2,166	-7,969	8,554	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-2,790	-	-2,643	-2,228	-1,140	129,164	129,851	129,118	230,798	108,142	0	0	0
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-5,668	11,700	-2,818	-3,243	-13,902	-63,547	-75,484	-22,508	-88,267	-50,660	68,451	22,586	0	0	0
Supplemental disclosure of non-cash investing and financing activities:
Accretion of redeemable convertible preferred stock to redemption values
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	92	0	0	0
Deferred offering costs included in accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Property and equipment included in accounts payable
-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Cash paid for interest
1,090	1,217	1,294	1,311	1,285	1,144	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	328	-	451	504	551	584	0	0	0	-	-	-	-